Friday, July 10, 2026

Drug profile · INN

pravastatin

pravastatin (PRAVACHOL) is a hmg-coa reductase inhibitor. Associated with Alphapharm Pty Ltd.

TGA: approved
Patents linked 1
Pipeline programs 6
News articles 0
Drug details — pravastatin

Quick answer

pravastatin (PRAVACHOL) is a hmg-coa reductase inhibitor. Associated with Alphapharm Pty Ltd.

Key facts

INN pravastatin
Brand PRAVACHOL
Mechanism HMG-CoA reductase inhibitor

Mechanism of action

HMG-CoA reductase inhibitor

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. IIBSP-PRE-2024-198 Phase 3 · George Institute for · intrauterine growth restriction, preeclampsia
  2. POST Triheptanoin Phase 2 · Ultragenyx UK · Frontal Lobe Hypometabolism
  3. PRAVASTATIN Phase 2 · George Institute for · Patients with severe and radio-induced breast fibrosis after
  4. Pravastatin sodium 80 mg tablets Phase 1 · Teva Pharma · Healthy
  5. pravastatin Phase 1 · Teva Pharma · Healthy
  6. pravastatin sodium Phase 1 · Teva Pharma · Healthy
  1. US 7425644

    Method of purifying pravastatin

    Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is pravastatin?

pravastatin (PRAVACHOL) is a hmg-coa reductase inhibitor. Associated with Alphapharm Pty Ltd.

What is the brand name for pravastatin?

PRAVACHOL is a marketed brand name for pravastatin. Check FDA Drugs@FDA for the current US label holder and prescribing information.